Mitochondrial complex I: Structure, function and pathology

被引:211
作者
Janssen, Rolf J. R. J. [1 ]
Nijtmans, Leo G. [1 ]
van den Heuvel, Lambert P. [1 ]
Smeitink, Jan A. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Lab Paediat & Neurol, Nijmegen Ctr Mitochondrial Disorders, Med Ctr, Nijmegen, Netherlands
关键词
D O I
10.1007/s10545-006-0362-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidative phosphorylation (OXPHOS) has a prominent role in energy metabolism of the cell. Being under bigenomic control, correct biogenesis and functioning of the OXPHOS system is dependent on the finely tuned interaction between the nuclear and the mitochondrial genome. This suggests that disturbances of the system can be caused by numerous genetic defects and can result in a variety of metabolic and biochemical alterations. Consequently, OXPHOS deficiencies manifest as a broad clinical spectrum. Complex 1, the biggest and most complicated enzyme complex of the OXPHOS system, has been subjected to thorough investigation in recent years. Significant progress has been made in the field of structure, composition, assembly, and pathology. Important gains in the understanding of the Goliath of the OXPHOS system are: exposing the electron transfer mechanism and solving the crystal structure of the peripheral arm, characterization of almost all subunits and some of their functions, and creating models to elucidate the assembly process with concomitant identification of assembly chaperones. Unravelling the intricate mechanisms underlying the functioning of this membrane-bound enzyme complex in health and disease will pave the way for developing adequate diagnostic procedures and advanced therapeutic treatment strategies.
引用
收藏
页码:499 / 515
页数:17
相关论文
共 134 条
  • [71] 2-G
  • [72] Martin, 1905, SURG GYNECOL OBSTET, V1, P62
  • [73] Mitochondrial DNA 3644T→C mutation associated with bipolar disorder
    Munakata, K
    Tanaka, M
    Mori, K
    Washizuka, S
    Yoneda, M
    Tajima, O
    Akiyama, T
    Nanko, S
    Kunugi, H
    Tadokoro, K
    Ozaki, N
    Inada, T
    Sakamoto, K
    Fukunaga, T
    Iijima, Y
    Iwata, N
    Tatsumi, M
    Yamada, K
    Yoshikawa, T
    Kato, T
    [J]. GENOMICS, 2004, 84 (06) : 1041 - 1050
  • [74] The subunit composition of the human NADH dehydrogenase obtained by rapid one-step immunopurification
    Murray, J
    Zhang, B
    Taylor, SW
    Oglesbee, D
    Fahy, E
    Marusich, MF
    Ghosh, SS
    Capaldi, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) : 13619 - 13622
  • [75] Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF
    Naini, AB
    Lu, JS
    Kaufmann, P
    Bernstein, RA
    Mancuso, M
    Bonilla, E
    Hirano, M
    DiMauro, S
    [J]. ARCHIVES OF NEUROLOGY, 2005, 62 (03) : 473 - 476
  • [76] Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins
    Nijtmans, LGJ
    de Jong, L
    Sanz, MA
    Coates, PJ
    Berden, JA
    Back, JW
    Muijsers, AO
    van der Spek, H
    Grivell, LA
    [J]. EMBO JOURNAL, 2000, 19 (11) : 2444 - 2451
  • [77] Nijtmans LGJ, 2004, TOP CURR GENET, V8, P149
  • [78] The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria
    Nolden, M
    Ehses, S
    Koppen, M
    Bernacchia, A
    Rugarli, EI
    Langer, T
    [J]. CELL, 2005, 123 (02) : 277 - 289
  • [79] A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy
    Ogilvie, I
    Kennaway, NG
    Shoubridge, EA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) : 2784 - 2792
  • [80] Conformation-driven and semiquinone-gated proton-pump mechanism in the NADH-ubiquinone oxidoreductase (complex I)
    Ohnishi, T
    Salerno, JC
    [J]. FEBS LETTERS, 2005, 579 (21) : 4555 - 4561